摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,4S,5S,6R)-4-(t-butyldimethylsiloxy)-6-(4-chlorobutyl)-2-methoxy-2-[[4,5-(R,R)-bis-(p-methoxybenzyloxy)-3-(R)-methyl-6-(R)-(2-methylallyl)-tetrahydropyran-2-(R)-yl]-((S)-p-methoxybenzyloxy)-methyl]-5-methyl-tetrahydropyran | 537041-15-9

中文名称
——
中文别名
——
英文名称
(2R,4S,5S,6R)-4-(t-butyldimethylsiloxy)-6-(4-chlorobutyl)-2-methoxy-2-[[4,5-(R,R)-bis-(p-methoxybenzyloxy)-3-(R)-methyl-6-(R)-(2-methylallyl)-tetrahydropyran-2-(R)-yl]-((S)-p-methoxybenzyloxy)-methyl]-5-methyl-tetrahydropyran
英文别名
[(2R,4S,5S,6R)-2-[(S)-[(2R,3R,4R,5R,6R)-4,5-bis[(4-methoxyphenyl)methoxy]-3-methyl-6-(2-methylprop-2-enyl)oxan-2-yl]-[(4-methoxyphenyl)methoxy]methyl]-6-(4-chlorobutyl)-2-methoxy-5-methyloxan-4-yl]oxy-tert-butyl-dimethylsilane
(2R,4S,5S,6R)-4-(t-butyldimethylsiloxy)-6-(4-chlorobutyl)-2-methoxy-2-[[4,5-(R,R)-bis-(p-methoxybenzyloxy)-3-(R)-methyl-6-(R)-(2-methylallyl)-tetrahydropyran-2-(R)-yl]-((S)-p-methoxybenzyloxy)-methyl]-5-methyl-tetrahydropyran化学式
CAS
537041-15-9
化学式
C52H77ClO10Si
mdl
——
分子量
925.716
InChiKey
LCWKMMZXQZDLQU-GHJOHHPZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    11.71
  • 重原子数:
    64
  • 可旋转键数:
    24
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    92.3
  • 氢给体数:
    0
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: fragment couplings, completion of the synthesis, analogue generation and biological evaluation
    作者:Ian Paterson、David Y.-K. Chen、Mark J. Coster、José L. Aceña、Jordi Bach、Debra J. Wallace
    DOI:10.1039/b504151a
    日期:——
    The antimitotic marine macrolide altohyrtin A/spongistatin 1 has been synthesised in a highly convergent and stereocontrolled manner, thus contributing to the replenishment of the largely exhausted material from the initial isolation work. Coupling of the AB- and CD-spiroacetal subunits by a stereoselective aldol reaction was achieved by using either a lithium (67 : 33 dr) or boron enolate (90 : 10
    抗有丝分裂海洋大环内酯altohyrtin A /海绵抑素1以高度会聚和立体控制的方式合成,因此有助于从最初的分离工作中补充大量消耗的物质。通过使用锂(67:33 dr)或烯醇硼(90:10 dr),通过立体选择性醛醇缩合反应将AB-和CD-螺缩醛亚基偶联。高度(Z)选择性的Wittig偶联用于将北半球醛与南半球salt盐结合在一起。在三醇癸二酸上进行脱保护并随后进行区域选择性大环内酯化,完成了altohyrtin A的合成。还制备了两种结构类似物,并评估了它们作为针对一系列人类肿瘤细胞系(包括紫杉醇抗性菌株)的生长抑制剂,
  • Synthesis and biological evaluation of spongistatin/altohyrtin analogues: E-ring dehydration and C46 side-chain truncationElectronic supplementary information (ESI) available: spectroscopic data for compounds 2 and 3. See http://www.rsc.org/suppdata/cc/b2/b212651f/
    作者:Ian Paterson、Jose L. Aceña、Jordi Bach、David Y.-K. Chen、Mark J. Coster
    DOI:10.1039/b212651f
    日期:2003.2.7
    Simplified analogues of the potent antimitotic marine macrolide spongistatin 1/altohyrtin A were synthesised and evaluated as growth inhibitory agents against a range of human tumour cell lines, including Taxol-resistant strains, revealing that E-ring dehydration leads to enhanced cytotoxicity at the low picomolar level while truncation of the side-chain at C46 results in a drastic decrease in activity.
    我们合成了强效抗沉迷海洋大环内酯 spongistatin 1/altohyrtin A 的简化类似物,并将其作为生长抑制剂对一系列人类肿瘤细胞系(包括 Taxol 抗性株)进行了评估,结果表明 E 环脱水可在低皮摩尔水平上增强细胞毒性,而 C46 侧链截断则会导致活性急剧下降。
  • Stereocontrolled Total Synthesis of (+)-Altohyrtin A/Spongistatin 1 Financial support was provided by the EPSRC (GR/L41646), Cambridge Commonwealth Trust (Scholarship to M.J.C.), EC (Marie Curie Postdoctoral Fellowship to J.L.A.), DFG (Postdoctoral Fellowship to T.T.), NSERC-Canada (Postdoctoral Fellowship to R.M.O.), Churchill College (Research Fellowship to D.J.W.), Kingapos;s College and Sims Fund, Cambridge (Scholarship to D.Y.K.C.). We also thank Merck and AstraZeneca Pharmaceuticals for generous support, and Dr. Anne Butlin (AZ) and Dr. Nick Bampos (Cambridge) for valuable assistance.
    作者:Ian Paterson、David Y.-K. Chen、Mark J. Coster、Jose L. Aceña、Jordi Bach、Karl R. Gibson、Linda E. Keown、Renata M. Oballa、Thomas Trieselmann、Debra J. Wallace、Andrew P. Hodgson、Roger D. Norcross
    DOI:10.1002/1521-3773(20011105)40:21<4055::aid-anie4055>3.0.co;2-h
    日期:2001.11.5
    antimitotic macrolide, altohyrtin A/spongistatin 1 shows great promise in cancer chemotherapy but its extreme scarcity in the natural sponges has halted its further preclinical development. A highly stereocontrolled total synthesis, which exploits boron-mediated aldol bond constructions, has been realized to provide, for the first time, a useful amount of synthetic material.
    作为一种异常有效的抗有丝分裂大环内酯,altohyrtin A / spongistatin 1在癌症化学疗法中显示出广阔的前景,但其天然海绵中的极度稀缺性阻止了其进一步的临床前开发。已经实现了利用硼介导的羟醛键结构的高度立体控制的全合成,首次提供了有用量的合成材料。
  • The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: the southern hemisphere EF segment
    作者:Ian Paterson、Mark J. Coster、David Y.-K. Chen、José L. Aceña、Jordi Bach、Linda E. Keown、Thomas Trieselmann
    DOI:10.1039/b504149j
    日期:——
    The fully functionalised C29-C51 southern hemisphere of altohyrtin A/spongistatin 1 , incorporating the E- and F-ring tetrahydropyran rings and the unsaturated side chain, has been synthesised in a highly convergent and stereocontrolled manner. Key steps in the synthesis of this phosphonium salt include four highly diastereoselective, substrate-controlled, boron aldol reactions to establish key C-C
    高度融合和立体控制的方式合成了功能完备的altohyrtin A /海绵抑素1的C29-C51南半球,其中包含E和F环四氢吡喃环和不饱和侧链。合成该salt盐的关键步骤包括四个高度非对映选择性,受底物控制的硼醇醛缩醛反应,以建立关键的CC键和相应的立体中心,其中通过利用远程异构体实现引入氯二烯侧链和带有C47羟基的中心。 F环四氢吡喃的立体诱导。
查看更多